Experience of stage I surgical resection for spontaneous rupture and hemorrhage of primary liver cancer
原发性肝癌自发性破裂出血的I期手术切除治疗的体会

摘要

目的 分析手术切除治疗原发性肝癌破裂出血的临床疗效。方法 选取2021年12月~2023年2月我院收治的原发性肝癌破裂出血患者，随机平均分为对照组与观察组，每组各45例，分别应用手术切除治疗与TACE治疗，对比两组疗效。结果 术后，两组总胆红素、白蛋白、血红蛋白、收缩压、舒张压水平对比（P＜0.05）。同时，两组预后方面及并发症方面对比，差异无统计学意义（P＞0.05）。结论 对于原发性肝癌自发性破裂出血患者应用TACE与手术切除治疗，疗效相差无几且效果较好。因此，可结合患者综合因素灵活选取适宜的治疗方式，有利于延长患者生存期。

Abstract

Objective To analyze the clinical effect of surgical resection in the treatment of ruptured hemorrhage of primary liver cancer.
Methods Patients with rupture and hemorrhage of primary liver cancer admitted to our hospital from December 2021 to February 2023 were randomly divided into control group and observation group, with 45 cases in each group, respectively. The therapeutic effects of the two groups were compared.
Results After operation, the levels of total bilirubin, albumin, hemoglobin, systolic blood pressure and diastolic blood pressure were compared between two groups (P < 0.05). At the same time, there was no significant difference in prognosis and complications between the two groups (P > 0.05).
Conclusion   There is no difference between TACE and surgical resection in the treatment of spontaneous rupture and hemorrhage of primary liver cancer. Therefore, the appropriate treatment can be flexibly selected according to the comprehensive factors of patients, which is conducive to prolonging the survival of patients.